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Self-peptides bound to MHCs in the thymus 
select a self-tolerant and self-MHC–restricted 
T cell repertoire. This is accomplished by im-
mature CD4+CD8+ double-positive (DP) thy-
mocytes interrogating these self-peptide–MHCs 
(pMHCs) with their TCRs. Strong TCR liga-
tion induces some portion of thymocytes to 
apoptose in a process known as negative selec-
tion, thus preventing those clones from emigrat-
ing to the periphery where they might mount 
a response against those same self-ligands (von 
Boehmer and Kisielow, 1990). Below a certain 
threshold, a signal of intermediate strength can 
instead induce maturation, allowing positive se-
lection of DP thymocytes into either the CD8+ 
or CD4+ single-positive (SP) T cell lineage 
(Huang et al., 2004). At an even lower threshold 
where a thymocyte’s TCR binds too weakly or 
not at all, it eventually dies by neglect.
These thresholds are best understood, in 
a quantitative sense, for the class I–restricted 
OT-I  TCR.  CD8+  SP  T  cells  bearing  this 
TCR recognize a chicken OVA257-264 peptide,   
SIINFEKL,  which  is  bound  to  H-2Kb  (Kb; 
Carbone  et  al.,  1988;  Carbone  and  Bevan, 
1989; Fremont et al., 1995). In vitro (Hogquist 
et al., 1994) or in vivo (Blanas et al., 1996), 
OVA peptide induces clonal deletion of OT-I 
TCR transgenic DP thymocytes. When mea-
sured by surface plasmon resonance (SPR), this 
negatively selecting interaction has a dissoci-
ation equilibrium constant (KD) of 6 µM at 
25°C (Alam et al., 1996, 1999). Further studies 
have determined the threshold between negative 
and positive selection in this system (Daniels 
et al., 2006) in terms of the apparent KD of a 
tetramerized OVA-Kb for the OT-I TCR and 
have shown that this threshold is similar across 
three  different  TCR  transgenic  systems  (T1, 
S14, and OT-I; Naeher et al., 2007). With 
respect to positively selecting ligands in the 
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T cell selection and maturation in the thymus depends on the interactions between T cell 
receptors (TCRs) and different self-peptide–major histocompatibility complex (pMHC) 
molecules. We show that the affinity of the OT-I TCR for its endogenous positively selecting 
ligands, Catnb-H-2Kb and Cappa1-H-2Kb, is significantly lower than for previously reported 
positively selecting altered peptide ligands. To understand how these extremely weak 
endogenous ligands produce signals in maturing thymocytes, we generated soluble mono-
meric and dimeric peptide–H-2Kb ligands. Soluble monomeric ovalbumin (OVA)-Kb molecules 
elicited no detectable signaling in OT-I thymocytes, whereas heterodimers of OVA-Kb paired 
with positively selecting or nonselecting endogenous peptides, but not an engineered null 
peptide, induced deletion. In contrast, dimer-induced positive selection was much more 
sensitive to the identity of the partner peptide. Catnb-Kb–Catnb-Kb homodimers, but not 
heterodimers of Catnb-Kb paired with a nonselecting peptide-Kb, induced positive selection, 
even though both ligands bind the OT-I TCR with detectable affinity. Thus, both positive 
and negative selection can be driven by dimeric but not monomeric ligands. In addition, 
positive selection has much more stringent requirements for the partner self-pMHC.
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Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
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cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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that self-peptides have a negligible effect on the response of 
OT-I CD8+ T cells to OVA-Kb (Spörri and Reis e Sousa, 2002). 
One complication inherent to both studies is the fact that 
RMA-S cells still retain a small number of their own endog-
enous pMHC complexes on their cell surface (Ljunggren 
et al., 1990). Furthermore, these studies were performed in sus-
pension cultures where biological outcomes, such as positive 
selection, cannot be observed because of the lack of some 
critical feature of thymic architecture. Therefore, by under-
taking studies using purified pMHCs that only present a sin-
gle peptide of choice, we hoped to clarify how self-peptides 
might work with agonist ligands to stimulate thymocytes.
In this study, we determined the affinity of interaction 
between the OT-I TCR and its two known naturally occur-
ring positively selecting ligands, Catnb-Kb and Cappa1-Kb 
(Santori et al., 2002), and found that these have significantly 
lower affinities for the OT-I TCR than the E1 and R4 APLs. 
To investigate how these and other self-peptides contribute 
to thymic selection, we developed a whole thymus culture 
system where positive and negative selection can be induced 
using soluble pMHC dimers without complications caused 
by unknown endogenous self-pMHCs on cell surfaces. Using 
this system, we showed that TCR dimerization by homo- or 
heterodimeric pMHCs is absolutely required for either type 
of selection. We further showed that a strong agonist pMHC 
can partner with most self-pMHCs to mediate negative 
selection, but TCR binding to the weaker pMHC is still 
required, as peptide variants that prohibit TCR interactions 
do not induce any calcium signaling or selection. In contrast, 
a strongly positively selecting pMHC must pair with another 
positively selecting pMHC to induce positive selection.
RESULTS
The affinity threshold for naturally occurring positively 
selecting ligands
It is generally accepted that during T cell development, stron-
ger pMHC ligands induce negative selection, whereas weaker 
self-pMHC ligands promote positive selection. Although mul-
tiple endogenous positively selecting peptides have been iden-
tified for the OT-I TCR, thus far dissociation constants (KDs) 
have only been experimentally determined for artificial posi-
tively selecting ligands (Alam et al., 1996, 1999). These are 
APLs based on exogenous agonist peptide, and because they 
do not occur naturally in the thymus, it is not completely 
clear how their affinities relate to physiological T cell selec-
tion events.
We therefore took advantage of the two known endog-
enous self-peptides (Catnb and Cappa1) that promote positive 
selection of the OT-I TCR (Santori et al., 2002). Using SPR, 
we measured the equilibrium KDs of OT-I binding to Catnb-Kb 
and Cappa1-Kb. Somewhat surprisingly, and in contrast to 
two positively selecting APLs in the OT-I system (E1 and R4), 
Catnb-Kb and Cappa1-Kb bound too weakly to accurately 
determine a KD using the same conditions as used to mea-
sure the KDs of E1 and R4 at 25°C (Alam et al., 1996, 1999). 
To overcome this limitation, we lowered the temperature to 
OT-I system, the monomeric KDs of two altered peptide 
ligands (APLs) that mediate positive selection have been mea-
sured using SPR (Alam et al., 1996, 1999). In these studies, it 
was demonstrated that positively selecting APLs, E1 and R4, 
have affinities that are 3.5–8.8× weaker than that of OVA-Kb 
(Alam et al., 1996, 1999). However, these APLs are not found 
in mice and so they could not be the natural positively select-
ing peptides for the OT-I TCR, and when the E1 peptide was 
expressed in OT-I TCR transgenic mice, it resulted in the 
selection of T cells that had a significantly altered reactivity 
toward antigen relative to normal OT-I TCR transgenic mice 
(Stefanski et al., 2001). Thus, it is not completely clear how 
the affinities of E1 and R4 relate to thymic events in vivo. 
More recently, 27 naturally occurring H-2Kb–bound peptides 
were identified by mass spectroscopy analysis (Santori et al., 
2002). Two of these, -catenin329-336 (Catnb) and F-actin 
capping protein A92-99 (Cappa1; Hogquist et al., 1997), although 
they are null ligands for mature OT-I T cells, were shown to 
mediate positive selection, but their affinities for the OT-I 
TCR have not been experimentally determined. This may be 
a result of their weaker binding to OT-I, which likely ap-
proaches the limit of what can be measured currently by avail-
able techniques such as SPR. Similarly, whether nonselecting 
pMHCs bind to OT-I TCR at all is not known because 
their affinities for TCR are expected to be even lower than 
positively selecting peptides and thus are also not measure-
able by current techniques.
In addition to their critical role during thymic selection, 
several studies have shown that self-pMHCs can contribute 
to signaling in response to foreign agonist pMHC during 
peripheral T cell activation. In the case of class II–restricted 
T cells, experiments using soluble dimeric pMHCs showed that 
certain endogenous pMHCs could synergize with an agonist 
pMHC in T cell activation (Krogsgaard et al., 2005). These 
studies fit well with studies from Wülfing et al. (2002) and 
Sumen et al. (2004) showing that APLs that did not induce 
activation on their own could, at a high concentration in the 
synapse, contribute to CD4+ T cell activation. In contrast, 
another study showed that in the context of artificial or cell 
surfaces, endogenous pMHC did not enhance TCR signaling 
in response to very low numbers of agonist pMHCs (Ma 
et al., 2008). However, the latter study could not rule out tran-
sient dimerization events of agonist or phenotypic differences 
in the T cells, which could cause reduced responsiveness to 
self-ligands without loss of sensitivity to foreign stimuli (Hogquist 
et al., 2003).
The contribution of self-pMHCs to agonist stimulation 
has also been demonstrated in the class I–restricted OT-I 
system using APCs derived from RMA cells that lacked the 
transporter associated with antigen processing (TAP; RMA-S). 
Again though, the results were mixed. One study concluded 
that there is an enhancement of agonist signaling in the pres-
ence of a large amount of any endogenous peptide-Kb on the 
surface of RMA-S cells that is independent of endogenous 
pMHCs’ affinity for the TCR (Yachi et al., 2005, 2007). 
Comparing RMA and RMA-S cells, another study concluded JEM VOL. 207, June 7, 2010 
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thereby allow signaling. It remained possible that DP thymo-
cytes, which are known to be more sensitive to pMHC li-
gands (Davey et al., 1998; Lucas et al., 1999; Li et al., 2007), 
might be able to detect and respond to monomeric pMHC. 
To test this hypothesis, we mixed soluble pMHC monomers 
with OT-I Kb/Db/ thymocytes loaded with the calcium 
indicator dye fura-2 and imaged them using time-lapse three-
dimensional (3D) fluorescence microscopy. We found that 
even at a protein concentration of 1 mg/ml (17 µM; which 
based on prior results should lead to 50% occupancy of the 
thymocytes’ TCRs [Naeher et al., 2007]), the high-affinity 
agonist  OVA-Kb  monomer  did  not  stimulate  OT-I  Kb/ 
Db/ thymocytes to any measureable degree (Fig. 2). Thus, 
even strong agonist pMHC monomers at high concentra-
tions could not stimulate thymocytes.
Next, we tested whether dimers of agonist peptide-Kbs or 
of various self-pMHCs could lead to calcium signaling in DP 
thymocytes. Kb dimers were constructed by including a free 
cysteine at the C terminus of the H-2Kb molecule and linking 
them using an 8-aa peptide containing two maleimide resi-
dues (as originally described by Cochran et al., 2000; Fig. S1). 
We first compared calcium flux induced by fast protein liq-
uid chromatography (FPLC)–purified homodimers of ago-
nist  OVA-Kb–OVA-Kb  with  that  induced  by  OVA-Kb 
monomers in OT-I Kb/Db/ thymocytes (Fig. 2). At 100 
µg/ml (0.87 µM), OVA-Kb–OVA-Kb dimers induced a 
sustained 1.5-fold increase in fura 340/380 ratio in thymocytes 
10°C to slow down the dissociation phase and were able to 
detect  specific  binding  by  Catnb-Kb  (KD  136  µM)  and 
Cappa1-Kb (KD 211 µM; Fig. 1). We also measured the af-
finity of OVA-Kb for OT-I (KD 8.7 µM) at 10°C to compare 
the KDs under the same conditions. In this way, we could 
show that Catnb-Kb has an affinity that is 15.6× lower than 
that of OVA-Kb, and Cappa1-Kb’s affinity is 24.3× lower 
than that of OVA-Kb. Previously, Alam et al. (1996, 1999) 
found  that  the  weakest  positively  selecting  peptide  ligand 
(R4) has an affinity that is 8.8× weaker than that of OVA-Kb. 
Thus, these naturally occurring positively selecting self-
peptide–Kb complexes have significantly lower affinities for 
the OT-I TCR. At the same time, these two pMHCs have 
affinities that are higher than that of a previously estimated 
highest affinity non–positively selecting APL (K4; Alam et al., 
1996). Thus, our data support the current threshold model of 
positive and negative selection; however, the range of affin-
ities that lead to positive selection is somewhat broader and 
lower than previously appreciated.
Dimeric TCR ligation is required for signaling  
and negative selection
We then set out to determine how TCR engagement with 
these low-affinity ligands might translate into cell fate deci-
sions. Previous studies have shown that in mature T cells, 
agonist pMHC monomers alone are insufficient to trigger 
signaling events and that dimerization of TCR is required 
(Cochran et al., 2001; Krogsgaard et al., 2005; Stone and 
Stern, 2006). Because the kinetics of ligand interaction are a 
critical parameter for TCR activation, the primary effect of 
dimerization could be to increase the operational affinity and 
Figure 1.  Affinity of naturally occurring positively selecting  
peptide-Kb ligands for the OT-I TCR. Equilibrium binding of soluble 
monomeric OVA-Kb, Catnb-Kb, and Cappa1-Kb to OT-I TCR measured by 
Biacore 3000 SPR at 10°C at various concentrations of peptide-Kb. Error 
bars show SE from three to five separate runs. The table indicates the 
name, the sequence of the peptide, the affinity (KD) in micromolar, the SE 
(± SE), and the goodness of fit (R2). The results are representative of at 
least three independent experiments. RU, relative units.
Figure 2.  Calcium signaling in thymocytes in response to high-
affinity pMHC. Soluble homodimers of agonist pMHCs can stimulate 
calcium signaling in thymocytes, whereas monomers of agonist pMHC 
cannot. (A) OT-I TCR transgenic Kb/Db/ thymocytes were loaded with 
fura-2, a ratiometric calcium-sensitive fluorescent dye (Tsien, 1989), and 
mixed with soluble OVA-Kb monomers (1 mg/ml or 17 µM) or OVA-Kb—
OVA-Kb homodimers (100 µg/ml or 0.87 µM). Representative Ca2+ ratio 
images obtained with fura-2 (340/380 nm) are shown in false color scale 
as indicated in the bottom right corner. (B) Fura-2 ratios (340/380 nm) 
were measured every 15 s for thymocytes in randomly chosen microscope 
fields, and their mean Ca2+ ratio was plotted as a function of time (fura 
ratio mean ± SEM; n = 7). The results are representative of at least three 
independent experiments.1226 Endogenous peptides in thymocyte selection | Juang et al.
population (Fig. 3 C), indicating significant negative selec-
tion. We also tested the effect of monomeric OVA-Kb that 
included the dimaleimide linker (with one free maleimide). 
Even at 50 µg/ml (0.87 µM), the monomer had no effect on 
the DP population in terms of numbers (Fig. 3 A) or up-
regulation of the activation marker CD69 (not depicted). 
This ruled out the possibility that the dimers exerted their 
effects via covalent attachment to cell surfaces. Our experi-
ments confirmed that DP thymocytes require the dimeric 
engagement of TCRs for negative selection (Fig. 3 B) and 
that monomer is insufficient even in whole thymi with 
normal 3D cellular interactions.
A role for low affinity self-peptides in negative selection
Using soluble heterodimers of agonist and self-pMHCs, we 
have previously shown that, for an MHC class II–restricted 
response, only certain endogenous pMHCs can assist agonist 
pMHC in T cell activation (Krogsgaard et al., 2005). At the 
same time, using antigen-presenting cells, Yachi et al. (2007) 
have shown in the class I–restricted OT-I system that the 
enhancement of agonist signaling by endogenous peptide-Kb 
is not endogenous peptide–specific and possibly relies more 
when compared with the completely nonstimulatory OVA-Kb 
monomer (Fig. 2). Because we observed by microscopy that 
individual thymocytes were not in contact with each other, 
we could rule out any role for cell–cell contact in this dimer-
mediated stimulation. Thus, OVA-Kb dimers can directly 
stimulate calcium signaling in thymocytes.
We then set out to confirm whether these early signaling 
events eventually lead to phenotypic changes in a more phys-
iological setting, which in this case was during thymic selec-
tion.  Previous  results  have  shown  that  adding  exogenous 
agonist OVA peptide to OT-I fetal thymic organ cultures 
(FTOCs) induces negative selection of the OT-I DP thymo-
cytes (Hogquist et al., 1993), and we examined whether ad-
dition of OVA-Kb–OVA-Kb dimers could induce negative 
selection of DPs in OT-I Kb/Db/ FTOCs, where the 
only MHC class I molecules present would be the soluble 
monomers or dimers that we added. Normally, a majority 
(50–70%) of thymocytes in OT-I Kb/Db/ thymi remain 
arrested at the DP stage because they lack endogenous posi-
tively selecting Kb molecules (Fig. 3 A). When we added as 
little  as  0.5  µg/ml  (0.0043  µM)  of  OVA-Kb–OVA-Kb  
dimers, there was a dramatic 2–4-fold decrease in the DP 
Figure 3.  Negative selection in FTOCs in response to dimeric pMHC. Agonist monomers cannot elicit negative selection in thymocytes, but agonist 
homodimers and agonist-self-peptide heterodimers induce negative selection in FTOC at a similar concentration. (A) Thymic lobes were excised from OT-I 
Kb/Db/ embryos at gestational day 16. One lobe from each pair was cultured with PBS, whereas the other was cultured with monomers of OVA-Kb 
(with the cross-linker attached) at 50 µg/ml (0.43 µM). Lobes were harvested after 4 d of culture, stained with anti-CD4 and anti-CD8, and analyzed by 
flow cytometry. Representative FACS plots are shown from three or more experiments per condition. (B) Thymic lobes were excised from OT-I Kb/Db/ 
embryos at gestational day 16 and co-cultured with homodimers of OVA-Kb–OVA-Kb, or with heterodimers OVA-Kb–Catnb-Kb, OVA-Kb–Cappa1-Kb, 
OVA-Kb–Mapk1-Kb, and OVA-Kb–Stat3-Kb at 5 µg/ml (0.043 µM). Lobes were harvested after 4 d of culture, stained with anti-CD4 and anti-CD8 antibod-
ies, and evaluated by flow cytometry. Representative FACS plots are shown from three or more experiments per condition. (C) Quantification of the data 
at different concentrations. The percent decrease in the number of CD4+CD8+ DP thymocytes was determined by dividing the difference in the percent of 
CD4+CD8+ DP population of the experimental lobe by the percentage of CD4+CD8+ DPs in the control lobe and multiplying by 100. Data are presented as 
mean ± SEM of three or more independent experiments.JEM VOL. 207, June 7, 2010 
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150 µg/ml (1.3 µM; Fig. 5 A and Fig. S2). Even at the highest 
concentration of 900 µg/ml (7.8 µM), we did not observe 
negative selection. As for the Cappa1-Kb–Cappa1-Kb ho-
modimers, we observed an increase in the CD8 SP popula-
tion in FTOCs only with very high concentrations (1.2 mg/ml 
or 10 µM) of protein (Fig. 5 B and Fig. S2). We were un-
able to induce positive selection at this concentration with 
Mapk1-Kb–Mapk1-Kb and Stat3-Kb–Stat3-Kb homodimers 
(Fig. 5 B and Fig. S2).
We have already shown, consistent with prior studies 
using mature T cells and exogenous peptides loaded onto 
APCs, that all of the tested self-peptides paired with OVA 
peptide could induce signaling and negative selection in 
OT-I FTOCs (Fig. 3 B). Because positive selection involves 
a weaker pMHC–TCR interaction than negative selection, 
we wondered if these self-peptides would be able to syner-
gize with Catnb to induce positive selection as they do with 
OVA to induce negative selection. To test this, we added 
Catnb-Kb–Cappa1-Kb, Catnb-Kb–Mapk1-Kb, and Catnb-Kb–
Stat3-Kb heterodimers to FTOCs at various concentrations. 
on the interaction of MHC class I with CD8 than with TCR. 
To test this with respect to thymic negative selection, we 
paired OVA-Kb with two positively selecting peptide-Kbs (Catnb 
and Cappa1) or two nonselecting peptide-Kbs (Mapk1 and 
Stat3). We added heterodimers of OVA-Kb–Catnb-Kb, OVA-
Kb–Cappa1-Kb,  OVA-Kb–Mapk1-Kb,  OVA-Kb–Stat3-Kb,  or 
OVA-Kb–OVA-Kb  (as  a  positive  control)  to  OT-I  Kb/ 
Db/  FTOC  at  various  concentrations.  Catnb,  Cappa1, 
Mapk1, and Stat3 are all nonstimulatory peptides for mature 
OT-I T cells. Catnb and Cappa1 induce positive selection 
in thymocytes but Mapk1 and Stat3 do not (Santori et al., 
2002). As shown in Fig. 3 (B and C), all of these hetero-
dimers lead to negative selection of OT-I Kb/Db/ thymo-
cytes at similar concentrations as OVA-Kb–OVA-Kb dimers 
(at 0.5–50 µg/ml or 0.0043–0.43 µM), as indicated by the 
dramatic decrease in the DP population. They are all similarly 
potent because as we titrated this effect down to 0.05 µg/ml 
(0.00043 µM), the OVA-Kb–OVA-Kb homodimers and all 
the OVA–self-heterodimers lost their ability to induce nega-
tive selection (Fig. 3 C). Our data demonstrate that OVA can 
synergize with any of these self-peptides to induce negative 
selection. Thus, our data are consistent with what has been 
previously observed for mature OT-I T cells interacting with 
APCs; most self-peptide-Kbs can synergize with agonist-Kbs 
to produce a strong signal.
The synergistic effect of paired pMHC is peptide sequence–
specific during positive selection
In the OT-I TCR system, Catnb and Cappa1 have been 
previously identified as naturally occurring positively select-
ing peptides that bind to H-2Kb (Santori et al., 2002). In 
terms of their strength, Catnb can induce positive selection at 
lower concentrations than Cappa1. In agreement with this, 
we have shown that Catnb-Kb has a higher affinity for OT-I 
than Cappa1-Kb (Fig. 1). We used these two peptides to 
examine the difference between monomeric and dimeric 
pMHC ligand requirements for calcium signaling and posi-
tive selection in FTOCs. For calcium signaling, we used live 
cell microscopy to determine whether dimers of various 
naturally occurring Kb-bound peptides (Catnb-Kb–Catnb-Kb, 
Cappa1-Kb–Cappa1-Kb, Mapk1-Kb–Mapk1-Kb, or Stat3-Kb–
Stat3-Kb) could stimulate thymocytes. We observed that only 
dimers of Catnb-Kb–Catnb-Kb and Cappa1-Kb–Cappa1-Kb 
induced calcium elevation in OT-I thymocytes at a protein 
concentration of 1 mg/ml (8.7 µM; Fig. 4). In contrast, none 
of the monomeric pMHC could stimulate OT-I DPs at the 
same concentration (Fig. 4 and not depicted) and neither 
could Mapk1-Kb or Stat3-Kb homodimers (Fig. 4).
We then examined whether these early signaling events 
correlated with the ability to induce positive selection in FTOC. 
As shown in Fig. 5 A, monomeric Catnb-Kb did not elicit any 
increase in the CD8+ SP thymocyte population when com-
pared with the PBS-treated control lobes (and neither did 
monomeric OVA-Kb [Fig. 3]). In contrast, Catnb-Kb–Catnb-Kb 
homodimer efficiently mediated positive selection of imma-
ture CD8+ SP T cells at or above protein concentrations of 
Figure 4.  Calcium signaling in thymocytes in response to low-
affinity dimeric pMHC. Soluble homodimers of Catnb-Kb and Cappa1-Kb 
can stimulate calcium signaling in thymocytes, whereas Catnb-Kb mono-
mers and Mapk1-Kb homodimers and Stat3-Kb homodimers cannot. 
(A) OT-I TCR transgenic Kb/Db/ thymocytes were loaded with fura-2 
and mixed with soluble Catnb-Kb monomers at 1 mg/ml (17 µM) or with 
Catnb-Kb–Catnb-Kb, Cappa1-Kb–Cappa1-Kb, Mapk1-Kb–Mapk1-Kb, or 
Stat3-Kb–Stat3-Kb homodimers at 1 mg/ml (8.7 µM). Representative Ca2+ 
ratio images were obtained with fura-2 (340/380 nm) and are shown 
using a false color scale as indicated in the bottom right corner.  
(B) Fura-2 ratios (340/380 nm) were measured every 15 s for thymocytes in 
randomly chosen microscopic fields and the mean Ca2+ ratio was plot-
ted as a function of time (fura ratio mean ± SEM; n = 7). The results 
are representative of at least three independent experiments.1228 Endogenous peptides in thymocyte selection | Juang et al.
and Fig. S2). This is a lower dose than is required to observe 
selection in response to Cappa1-Kb–Cappa1-Kb homodimers   
(1,200 µg/ml; 10 µM). Similarly, we found that only Catnb-Kb–
Cappa1-Kb heterodimers are able to induce robust calcium 
signaling  when  compared  with  Catnb-Kb–Mapk1-Kb  and 
Catnb-Kb–Stat3-Kb heterodimers at 1 mg/ml (8.7 µM; Fig. S3). 
Therefore, in positive selection we could observe a synergistic 
In FTOCs cultured with Catnb-Kb–Mapk1-Kb and Catnb-Kb–
Stat3-Kb, there were no significant differences between the 
CD4/CD8 profiles when compared with controls (Fig. 5 C) at 
the highest tested protein concentration. However, we ob-
served a dramatic increase in the CD8+ SP population with 
Catnb-Kb–Cappa1-Kb heterodimers at 600 µg/ml (5.2 µM) and   
900 µg/ml (7.8 µM) but not at 300 µg/ml (2.6 µM; Fig. 5 C 
Figure 5.  Positive selection in FTOCs in response to low-affinity dimeric pMHC. Soluble dimers of particular combinations of self-peptide–Kb 
molecules induce positive selection in OT-I Kb/Db/ FTOC. Thymic lobes were excised from OT-I Kb/Db/ embryos at gestational day 16 and 
co-cultured with monomers and dimers of endogenous pMHCs at the indicated concentrations. Lobes were harvested after 4 d of culture, stained with 
anti-CD4 and anti-CD8 antibodies, and evaluated by flow cytometry. (A) These representative FACS plots compare lobes treated with monomeric Catnb-
Kb (with the cross-linker attached) to lobes treated with dimeric Catnb-Kb–Catnb-Kb at the indicated protein concentrations. (B) Representative flow 
cytometry plots comparing lobes treated with a high concentration (1,200 µg/ml or 10 µM) of homodimers (Stat3-Kb–Stat3-Kb, Mapk1-Kb–Mapk1-Kb, or 
Cappa1-Kb–Cappa1-Kb). (C) Representative flow cytometry plots comparing lobes treated with heterodimers (Catnb-Kb–Cappa1-Kb, Catnb-Kb–Mapk1-Kb, 
or Catnb-Kb–Stat3-Kb) at the indicated protein concentrations. The results are representative of at least three independent experiments.JEM VOL. 207, June 7, 2010 
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Engineered null ligands abolish the synergistic effect of 
paired pMHC
Considering  the  peptide  specificity  requirement  for  both 
partners of the dimeric pMHC during positive selection, our 
data suggest that the affinity of the partner pMHC interaction 
is important for its synergistic contribution. However, the 
partner self-pMHC’s affinity requirement has not been dem-
onstrated for agonist signaling such as the signaling leading to 
negative selection. To reconcile the difference between posi-
tive and negative selection and to determine this self-peptide 
specificity requirement, we paired the lowest affinity SIAAF-
ASL peptide-Kb with OVA-Kb in the context of a soluble het-
erodimer. This heterodimer was mixed with OT-I thymocytes 
loaded with fura-2 ratiometric dye to measure the intracellular 
increase in calcium levels by microscopy. At 100 µg/ml 
(0.87 µM), OVA-Kb–SIAAFASL-Kb heterodimers could not 
stimulate OT-I thymocytes, unlike homodimers of OVA-
Kb–OVA-Kb (Fig. 6 B) or heterodimers of OVA-Kb–Stat3-Kb 
(Fig.  3).  Similarly,  FTOC  co-cultured  with  OVA-Kb–
SIAAFASL-Kb heterodimers at 200 µg/ml or 1.74 µM (which 
is 400-fold higher than the concentration of OVA-Kb–OVA-Kb 
homodimers which is required to cause negative selection) 
showed no signs of negative selection (Fig. 6 C). It is not 
clear how SIAAFASL disrupts TCR binding in terms of its 
structure. It was designed to minimize TCR contacts, but 
from a structural model (unpublished data) we cannot rule 
out the possibility that it also alters Kb docking and/or the 
surrounding Kb structure, which might also influence CD8 
binding. So in addition, we used SIINFEK(BIO)L, where the 
only modification is to a TCR-contacting residue (a biotin 
group added on to K) which does not impinge on the MHC 
structure (Fremont et al., 1995; Turner et al., 1997). Like-
wise, SIINFEK(BIO)L-Kb homodimers showed no detectable 
binding on SPR when compared with Cappa1-Kb homo-
dimers under the same conditions (Fig. S5). And similarly, this 
APL could not induce Ca2+ when paired with OVA-Kb (as 
an OVA-Kb–SIINFEK(BIO)L-Kb heterodimer; Fig. 6 B) nor 
promote negative selection at high protein concentrations 
(Fig. 6 C). Thus, even a strong OVA-Kb ligand must pair 
with a partner that is able to bind to the TCR, although this 
partner only needs to bind TCR very weakly.
DISCUSSION
In this paper, we introduce and demonstrate the utility of an 
in vitro system in which we can induce either positive or 
negative thymic selection with soluble pMHC dimers. We 
use this to show an absolute requirement for dimeric pMHC 
in both types of thymic selection, which strongly indicates 
that bringing together two distinct TCR–CD3 complexes 
rather than just engaging individual TCRs is essential for 
thymocyte signaling. This parallels work on T cell activation 
where most (Boniface et al., 1998; Cochran et al., 2001; 
Krogsgaard et al., 2005; Stone and Stern, 2006) although not 
all (Delon et al., 1998; Ma et al., 2008) studies show that 
soluble pMHC dimers, and not monomers, activate mature 
T cells. In contrast to a prior study, which showed positive 
effect of Cappa1-Kb contributing to Catnb-Kb stimulation. 
Moreover, our studies using lower affinity positively selecting 
ligands reveal something quite different to what we and others 
have observed for negatively selecting ligands. In this case, 
the synergistic effect is in fact peptide specific, as only the 
stronger Cappa1-Kb self-ligand could partner with Catnb-Kb to 
produce an appreciable T cell response, whereas the weaker 
Mapk1-Kb and Stat3-Kb could not.
Nonnegligible affinity of null self-peptide–Kb for OT-I
One possibility that might reconcile these results is that the abil-
ity of self-peptides to synergize with a stronger ligand is self-
peptide–specific in both positive and negative selection. In this 
case, because of OVA-Kb’s high affinity for the OT-I TCR, 
the affinity of the partner self-peptides involved in negative se-
lection might span a much larger affinity range and still allow 
productive TCR signaling. In this view, we would predict 
that the various known self-peptide–Kbs do in fact have some 
appreciable affinity for the OT-I TCR, even if alone they are 
null ligands in terms of stimulatory capability. These affinities 
must be very low, as Mapk1-Kb and Stat3-Kb (ligands that 
could  partner  with  OVA-Kb  to  induce  negative  selection) 
showed undetectable binding in SPR, which generally sets a 
limit in the range of 300 µM for molecules of this size and solu-
bility. Nonetheless, we have shown here that a KD as low as 
211 µM is sufficient for Cappa1 to drive positive selection of 
OT-I T cells. Self-pMHC with affinities only twofold lower 
for OT-I would not be measureable yet might still make some 
peptide-specific contribution to OT-I T cell triggering.
To explore this possibility, we measured the affinities of 
dimeric self-peptide–Kbs for the OT-I TCR using SPR. Dimer-
ization makes accurate calculation of a KD impossible because 
of cooperativity effects. But using soluble dimers in SPR does 
allow us to determine whether or not particular self-peptide–Kb 
can bind to the OT-I TCR at all. We saturated the surface of 
streptavidin sensor chips with biotinylated OT-I TCR and 
used different combinations of foreign and self-pMHC di-
mers as analytes. In these measurements, we also used the 
peptide SIAAFASL, an APL of OVA (SIINFEKL) which we 
designed to minimize contacts with the OT-I TCR based on 
structural  and  T  cell  reactivity  data  (Jameson  and  Bevan, 
1992; Matsumura et al., 1992; Saito et al., 1993; Hogquist et 
al., 1994; Fremont et al., 1995) and which binds to H-2Kb 
comparably with the other peptides tested (Fig. S4). We mea-
sured the binding of 5 µM of Catnb-Kb–Catnb-Kb, Cappa1-
Kb–Cappa1-Kb,  Mapk1-Kb–Mapk1-Kb,  Stat3-Kb–Stat3-Kb, 
and SIAAFASL-Kb–SIAAFASL-Kb dimers on the same OT-
I ligand surface, and their relative affinities are given in Fig. 
6 A. As expected from SPR measurements of self-Kb mono-
mers (Fig. 1), Catnb-Kb and Cappa1-Kb dimers showed the 
highest level of binding (respectively) to OT-I TCR. Our 
engineered null SIAAFASL-Kb complex showed no detect-
able binding even as a dimer. But most importantly, the other 
self-ligands, Mapk1-Kb and Stat3-Kb, which had no biologi-
cal activity in our positive selection assay, nonetheless dis-
played weak but significant affinity for the OT-I TCR.1230 Endogenous peptides in thymocyte selection | Juang et al.
Figure 6.  TCR affinity determines the thymic selection outcome, even for very weak ligands. (A) Sensorgram of the interaction between immo-
bilized OT-I TCR at high density with 5 µM Catnb-Kb–Catnb-Kb, Cappa1-Kb–Cappa1-Kb, Mapk1-Kb–Mapk1-Kb, Stat3-Kb–Stat3-Kb, and SIAAFASL-Kb–SIAAFASL-Kb 
homodimeric pMHC. (B) Mean Ca2+ ratio of thymocytes mixed with 100 µg/ml (0.87 µM) of OVA-Kb–OVA-Kb, OVA-Kb–SIAAFASL-Kb, or OVA-Kb–
SIINFEK(BIO)L-Kb. (C) Thymic lobes were excised from OT-I Kb/Db/ embryos at gestational day 16 and co-cultured with homodimers of OVA-Kb–
OVA-Kb or with heterodimers OVA-Kb–SIAAFASL-Kb and OVA-Kb–SIINFEK(BIO)L-Kb at various concentrations. Lobes were harvested after 4 d of culture, 
stained with anti-CD4 and anti-CD8 antibodies, and evaluated by flow cytometry. The percent decrease in the number of CD4+ CD8+ DP thymocytes was 
determined by dividing the difference in the percentage of CD4+CD8+ DP population of the experimental lobe by the percent of CD4+CD8+ DPs in the 
control lobe and multiplying by 100. Data are presented as mean ± SEM of three or more independent experiments. (D) A graph summarizing the 
relationship between pMHC-TCR affinity and thymic selection outcomes. Steady-state KDs measured at 10°C of monomeric and dimeric peptide-Kb binding 
to OT-I TCR are indicated in the bottom of the graph. * and ‡ represent monomeric KD measurements at 25°C that were obtained previously by Alam et al. 
(1996) and Alam et al. (1999), respectively.JEM VOL. 207, June 7, 2010 
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explanation for these studies’ contradictory data. Using our 
system, we find that there is a TCR specificity requirement 
for the partnering endogenous ligand in both positive and 
negative selection. Our results agree more with the study of 
Yachi et al. (2007) in that endogenous pMHC could enhance 
thymocyte activation in the presence of a high-affinity ligand. 
However, this enhancement is peptide specific, as shown by 
the inability of SIAAFASL-Kb and SIINFEK(BIO)L-Kb to 
partner with OVA-Kb to provoke a response. We think it 
likely that the seven self-peptides tested in prior studies 
(Yachi et al., 2007) might have some nonnegligible affinity 
for the OT-I TCR that could allow them to assist OVA pep-
tide in T cell activation. We have shown by SPR that at least 
two of these peptides, Mapk1 and Stat3, have measurable af-
finity in dimeric form when compared with an engineered 
null peptide. Whether any truly null self-p–Kb exists endog-
enously is unknown, but, nonetheless, our data show that the 
ability of self-p–Kb to enable the response to OVA-Kb relies 
on the TCR’s low affinity for those self-peptide–Kbs. The larger 
number of self-p–Kbs that are able to contribute to agonist 
signaling (compared with the class II systems [Krogsgaard et al., 
2005; Ebert et al., 2009; Lo et al., 2009]) likely reflects the 
ability of CD8–class I binding to compensate for weaker 
TCR-pMHC binding (Yachi et al., 2007).
We  have  measured  OT-I’s  affinity  for  Catnb-Kb  and 
Cappa1-Kb as monomers, but many more self-p–Kbs bind too 
weakly to accurately measure, even though we have shown that 
their affinity in a dimeric form is detectable and relevant for 
TCR signaling. One drawback of measuring multivalent modes 
of binding is that the binding enhancement is a result of both 
the simultaneous spanning of two binding sites and of an in-
creased local concentration of available ligand. This coopera-
tivity factor is different for each pMHC complex, thus one 
cannot accurately estimate the monomeric affinity of the 
TCR using this method. Despite this, several studies have 
used measurements of multimeric affinities to examine the 
threshold separating negative and positive selection (Daniels 
et al., 2006; Naeher et al., 2007). In this study, we have pro-
vided affinity rankings for an agonist, several self-pMHCs, 
and a null pMHC ligand for the OT-I TCR in monomeric 
and dimeric form at 10°C. The dimeric affinities correlate 
with selection outcomes and also with monomeric affinities. 
Specifically, we showed that dimers of Mapk1-Kb have a 
higher affinity than Stat3-Kb dimers, whereas we could not 
detect binding of OT-I to Stat3-Kb monomers and could 
barely detect binding of OT-I to  Mapk1-Kb  monomers. 
Our  ranking  indicates  that  the  affinity  of  monomeric 
SIAAFASL-Kb is weaker than that of Stat3-Kb because we 
could not detect any binding of the dimeric SIAAFASL-Kb. 
The codon model (Feng et al., 2007; Rubtsova et al., 2009) 
of TCR recognition predicts that the OT-I TCR should 
retain some complementarity to the invariant helices of 
H-2Kb’s peptide-binding cleft, regardless of the peptide (un-
less TCR binding is sterically blocked, as in the case of 
SIINFEK(bio)L-Kb). In contrast, the SIINFEKL P3 position 
contacts Kb’s -2 helix (Fremont et al., 1995), and replacing 
selection in response to soluble OVA-Kb molecules (Mintern 
et al., 2004), our data using OVA-Kb dimers agree more with 
studies (Hogquist et al., 1994, 1995; Jameson et al., 1995; 
Daniels et al., 2006) that show that strong agonist ligands do 
not mediate positive selection of OT-I CD8+ T cells.
We also find that the requisite peptide components of di-
meric pMHC vary significantly between negative and positive 
selection. Although negative selection can be mediated by di-
merization of a strong negatively selecting ligand partnered with 
various nonselecting self-pMHC ligands, positive selection re-
quires that both of the dimer’s peptides be positively selecting 
ligands. This observation may help to explain the extreme sensi-
tivity of DP thymocytes toward negatively selecting ligands. 
That is, even if a rare high-affinity ligand is present in minute 
amounts, it can pair with any of many lower affinity ligands on 
an APC to induce negative selection. This feature could help to 
explain how thymocytes are able to detect and respond to very 
small numbers of cognate agonist peptides (Kurts et al., 1996; 
Peterson et al., 1999; Ebert et al., 2008), which is thought to 
help enforce the efficiency of thymic self-tolerization.
Our results also have implications for the stringency of 
positive selection. A previous study showed that only 4–8% of 
the preselection T cell repertoire is restricted to self-MHC 
(Zerrahn et al., 1997), and yet primary T cell responses in the 
periphery depend on the frequency of their naive precursors 
(Moon et al., 2007). These results underscore the critical role for 
positive selection in producing an optimally self-compatible 
repertoire. At the same time, positively selecting peptides in 
the thymus account for <10% of self-peptides examined in 
several systems (Baldwin et al., 1999; Santori et al., 2002; 
Ebert et al., 2009; Lo et al., 2009), and we know that positive 
selection is limited by the availability of these particular self-
pMHCs (Hogquist et al., 1993; Merkenschlager, 1996). Our 
results show that positive selection requires dimerization of 
an already limited set of positively selecting ligands, and this 
mode of binding seems likely to inhibit the maturation of 
clones that only recognize very rare self-pMHCs. That is, if 
p is the probability of encountering a single positively select-
ing self-pMHC, then the probability of encountering two 
positively selecting ligands in proximity of each other would 
be proportional to p2, which diminishes rapidly as p becomes 
small. Thus, requiring that thymocytes engage two pMHCs 
simultaneously would help to select TCRs that are compatible 
with the most abundant self-pMHCs. By the same token, this 
mode of binding could help to explain how positive selection 
encourages polyspecificity of TCRs for self-pMHC (Huseby 
et al., 2005). Negative selection would inhibit polyspecificity 
to some degree (Huseby et al., 2005), but the ability to recog-
nize multiple distinct ligands might be useful for responding 
to more diverse antigens (Wucherpfennig et al., 2007).
Our experimental system successfully restricts thymocyte 
interactions to exogenously supplied soluble self-pMHC 
complexes only. This is an advantage over previous studies 
using antigen-presenting cells (Spörri and Reis e Sousa, 2002; 
Yachi et al., 2007), which involve many more components 
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analyzed for purity by mass spectrometry. Peptide-based cross-linking re-
agents (Schafer-N) were constructed and purified essentially as described 
(Krogsgaard et al., 2005). The protein concentration was estimated by UV 
absorbance at 280nm. Immediately before use, pMHC complexes were 
purified by FPLC on a Superdex S200 column (GE Healthcare) to re-
move aggregates.
FTOC. Thymic lobes were excised from fetuses at gestational day 16. The 
lobes were placed on ISOPORE membrane filters (Millipore) on top of MF 
support Pads (Millipore) in 24-well plates with standard RPMI complete 
medium (Ebert et al., 2008). Soluble H-2Kb molecules were added to the 
culture at the indicated concentrations. After 4 d in culture, the thymic lobes 
were harvested and thymocytes were extruded mechanically by pressing the 
tissue through a nylon mesh.
BIACORE analysis. All SPR experiments were performed at 10°C on a   
Biacore 3000 instrument (GE Healthcare) as previously described (Krogsgaard 
et al., 2003). In brief, biotinylated OT-I TCRs were captured on streptavidin-
coated sensor chips (Sensor Chip SA; GE Healthcare) that were pretreated ac-
cording to the manufacturer’s instructions. As a control, biotinylated MCC-IEK 
was also captured on the same sensor chip. The specific binding of peptide-Kb 
and OT-I was measured using the in-line reference subtraction feature of the 
Biacore 3000 instrument. Increasing concentrations of monomeric and di-
meric peptide-Kb were injected at a flow rate of 60 µl/min over all four sur-
faces of the sensor chip. The monomeric TCR/pMHC steady-state affinity 
was calculated by plotting the mean maximal response at steady state for 
each concentration versus pMHC concentration and fitting the data in 
BIAevaluation software (version 4.1; GE Healthcare) to the equation 
Response = (Rmax × C)/(KD + C), which describes the simple 1:1 binding of 
a ligand that follows the law of mass action, where C is the concentration 
of pMHC.
Antibodies and flow cytometry. Cell surface molecules were stained 
with anti–H-2Kb (AF6-88.5), anti-V2 TCR (B20.1), anti-CD69 (H1.2F3), 
anti-CD62L (MEL-14), and anti-CD4 (RM4-5) antibodies (all obtained 
from BD). The anti-CD8 antibody was purchased from eBioscience. Live 
cells were identified by their forward- and side-scatter profiles. Samples were 
run on a FACStar flow cytometer (BD) and analyzed with FlowJo soft-
ware (version 8.8.6; Tree Star, Inc.).
Microscopy. Microscopy and data analysis were performed using a micro-
scope (Axiovert S100TV; Carl Zeiss, Inc.) and MetaMorph (Universal Im-
aging Corporation) 3D time-lapse system using a 40× Fluor objective (NA 1.3) 
as previously described (Huppa et al., 2003). Thymocytes were isolated by 
removing whole thymi into cold complete RPMI and disrupting the tissue 
by pushing it through a nylon mesh. Before imaging, thymocytes were 
loaded with 10 mM fura-2(AM) (Invitrogen) in medium for 20 min at room 
temperature and washed three times in imaging medium (Hepes-buffered 
saline) plus 5% FCS, 0.5 mM CaCl2, and 0.1 mM MgCl2). For time-lapse 
experiments using purified protein, OT-I Kb/Db/ thymocytes in imag-
ing medium were mixed with purified pMHC dimers or pMHC monomers 
(kept on ice) and imaged in an FCS2 chamber (Bioptechs, Inc.) at 37°C as 
previously described (Krogsgaard et al., 2005). As an indicator of intracellular 
Ca2+ concentration, fura-2 fluorescence ratios (340/380 nm) were deter-
mined as previously described (Huppa et al., 2003).
Online supplemental material. Fig. S1 shows that pMHC dimers, not 
oligomers, are purified and used for calcium imaging and FTOC. Fig. S2 
shows the percent change in CD8 SP in FTOC in response to an assortment 
of dimeric pMHC ligands at various concentrations. Fig. S3 shows the cal-
cium signaling response of thymocytes mixed with low-affinity heterodi-
meric pMHC. Fig. S4 shows the relatively similar H-2Kb binding affinity of 
peptides used in the study by a peptide competition assay. Fig. S5 shows the 
relative OT-I TCR affinity of SIINFEK(BIO)L-Kb homodimers in comparison 
to Cappa1-Kb homodimers. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20092170/DC1.
I with A at this position may impinge on the MHC’s confor-
mation. So SIAAFASL may represent a truly null peptide, 
but we cannot rule out the possibility that it has an ex-
tremely low affinity that falls below the threshold required to 
support signaling as a partner in a heterodimer and below the 
threshold for detection as a dimer by SPR.
Therefore, based on an affinity gradient (Alam et al., 1996; 
Fig. 6 D), our data suggest that pMHCs with high TCR affin-
ity (<8 µM, e.g., OVA-Kb/OT-I) would induce negative 
selection when paired with ligands above another much lower 
threshold.  This  partner  threshold  falls  somewhere  between 
SIAAFASL-Kb and Stat3-Kb and we can only measure appar-
ent affinities of dimers at 10°C in this range. But the threshold 
for the partner ligand during positive selection is measurably 
higher. So far, we have only found one other positively select-
ing ligand to be sufficient: Cappa1-Kb, which binds OT-I with 
a monomeric binding affinity of 211 µM, which is 24-fold 
weaker than OVA-Kb, at 10°C. We predict that this partner 
threshold would lie somewhere between the monomer-
measureable and dimer-measurable ranges, 250–400 µM, 
although this lower bound estimate is necessarily not very 
accurate in terms of monomeric affinity. Finally, we showed 
that the range of naturally occurring positively selecting pMHC 
affinities is broader and lower than previously appreciated: 
100–250 µM in terms of monomeric affinity at 10°C. Our re-
sults extend the affinity model for predicting selection out-
come to significantly lower affinities and suggest that TCR 
interactions with extremely weak self-ligands can play an im-
portant role in both positive and negative selection.
MATERIALS AND METHODS
Mice.  To  obtain  OT-I  Kb/Db/  mice,  OT-I  mice  (C57BL/6-
Tg(TcraTcrb)1100Mjb/J;  The  Jackson  Laboratory)  were  crossed  with 
Kb/Db/ mice (C57BL/6Ji-Kbtm1Dbtm1 N12; Taconic). All mice were 
bred and maintained at the Stanford University Department of Comparative 
Medicine Animal Facility (protocol 3540) in accordance with National 
Institutes of Health guidelines.
Expression of soluble OT-I TCR molecules. The OT-I TCR  chain 
with an acidic zipper and a  chain with a basic zipper have been previously de-
scribed (Fremont et al., 1995) and were expressed in the pAcGP67A vector. We 
added a BirA site to the C terminus of the OT-I TCR  chain by PCR using 
the  5-GGAAGATCTTTATTCATGCCATTCAATCTTTTGAGCTTC-
GAAAATATCATTAAGTCCCTGAGCCAGTTCCTTTTCCGGTG-3 
primer to enable biotin binding for SPR analysis. The soluble OT-I TCR with 
this BirA site was expressed in a Baculovirus expression system and purified as 
described previously (Garcia et al., 1996). Site-specific biotinylation was per-
formed as previously described (Boniface et al., 1998).
Soluble p–H-2Kb complexes. The genes for murine class I H-2Kb (in-
cluding the connecting peptide region) and a Ser-Gly-Gly-Cys sequence 
(for cross-linking) were amplified by PCR from OT-I cDNA. For con-
structs to be used for refolding with peptides, the genes were fused in frame 
with T7 or His sequences in a modified PET28a(+) vector (EMD) for sub-
sequent affinity purification (Krogsgaard et al., 2005). Soluble murine class I 
MHC proteins H-2Kb and human Beta 2 Microglobulin were produced by 
expression as inclusion bodies in Escherichia coli, purified and refolded in vitro 
in the presence of peptide, as described for mice class II MHC proteins (Altman 
et al., 1993). The peptides OVA257-264 (SIINFEKL), Catnb329-336 (RTYTYEKL), 
Cappa192-99(ISFKFDHL), Mapk119-26(VGPRYTNL), Stat353-60(ATLVFHNL), 
SIAAFASL, and SIINFEK(BIO)L (Bio-Synthesis Inc.) were purchased and JEM VOL. 207, June 7, 2010 
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